Alkami Technology, Inc. (ALKT) Misses Q2 EPS by 23c ; Offers Guidance

Alkami Technology, Inc. (NASDAQ: ALKT) reported Q2 EPS of ($0.08), $0.23 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $128.68 million.

GUIDANCE:

Alkami Technology, Inc. sees Q3 2026 revenue of $132.7-134.2 million, versus the consensus of $134 million.

Alkami Technology, Inc. sees FY2026 revenue of $528-531 million, versus the consensus of $529.7 million.

For earnings history and earnings-related data on Alkami Technology, Inc. (ALKT) click here.

You May Also Be Interested In

• Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy
• Piper Sandler Upgrades Tempus AI Inc (TEM) to Overweight, 'On A Train Back To Upside, We're Not Jumping the Gun'
• Lucid Capital Markets Assumes Nuvectis Pharma (NVCT) at Buy